Drug Utilization Review Programs; Confidentiality of Enrollees

Checkout our iOS App for a better way to browser and research.

Sec. 5. The name of an enrollee that is discovered in the course of the drug utilization review program shall remain confidential.

As added by P.L.69-1998, SEC.16.


Download our app to see the most-to-date content.